The platforms feature AI-powered imaging, helium-free MR technology, and designs focused on long-term operational value and efficiency.
At the American Society for Radiation Oncology 2025 Annual Meeting, Philips introduced new imaging systems for radiation therapy, including the Rembra RT and Areta RT computed tomography (CT) platforms and the BlueSeal RT 1.5T magnetic resonance (MR) system.
The new Rembra RT and Areta RT CT systems are designed to improve the speed and accuracy of cancer treatment planning. The platforms feature a new NanoPanel Precise XD detector and offer image reconstruction speeds of up to 106 images per second. The systems include a Tube for Life Guarantee and a design intended to support 20 years of service with upgrades and maintenance. Additional features include remote collaboration for planning and training, and shared-use radiology capabilities on the Rembra RT model to maximize departmental use.
“With Rembra RT and Areta RT, we’re once again setting new standards in radiation therapy, empowering care teams with the precision, dependability, and speed they need to deliver the best outcomes for patients,” says Dan Xu, business leader of CT at Philips, in a release.
Philips also announced it is exploring the integration of MVision AI’s Contour+ auto-segmentation software with its new CT simulators to automate the delineation of organs and lymph node areas.
Helium-Free MR for Radiotherapy
Alongside the CT systems, the company is introducing its BlueSeal MR RT system to the North American market. The system uses a helium-free magnet and is powered by AI-based SmartSpeed Precise acceleration software to enhance simulation confidence.
From a facility and operational standpoint, the system’s light-weight, vent-pipe-free design allows for more flexible siting options within a hospital, including basements or higher floors, while reducing costs and energy consumption. The company states that full MR-only simulation protocols can be completed in as little as 10 minutes, shortening scan times for patients.
“BlueSeal RT is leading the way in MR for radiotherapy,” says Ioannis Panagiotelis, PhD, business leader MR at Philips, in a release. “By combining helium-free sustainability with AI-powered acceleration, we’re enabling radiation oncology teams to plan and simulate with greater speed, accuracy, and confidence—while enhancing the patient experience.”
Photo caption: Rembra RT CT platform
Photo credit: Philips
